FUS and amyotrophic lateral sclerosis: These data provide compelling genetic evidence that the onset and progression of MN loss in this mouse model of FUS-ALS is a cell-autonomous process and that, to the extent that other cells (for example, astrocytes and microglia) contribute to neurodegeneration, this occurs independent of the expression of mutant FUS, with no evidence of a cell-non-autonomous mechanism.